Circulatory system disease
Conditions
Interventions
Control group:Intravenous injection of Remazolam 0.3mg/kg was completed within 30s. When BIS value =60, then intravenous injection of Sufentanil 0.3µg/kg and rocuronium 0.6mg/kg was given. On this bas
Observation group:Intravenous injection of Remazolam 0.3mg/kg was completed within 30s. When BIS value =60, then intravenous injection of Sufentanil 0.3µg/kg and rocuronium 0.6mg/kg was given. 1mg/kg
Sponsors
Ningbo Medical Center-Li Huili Hospital
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 20-60 years old, body mass index (BMI) 18-24kg /m^2, ASA grade I to II, no obvious heart, liver, kidney, lung disease, patients understand the clinical trial, signed the informed consent
Exclusion criteria
Exclusion criteria: 1: Allergic to analgesic, sedative and experimental drugs, psychiatric and nervous system diseases, respiratory and other systemic diseases. 2.difficult airway
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean arterial pressure;Heart rate; | — |
Countries
China
Contacts
Public ContactChen Qianqian
Ningbo Medical Center-Li Huili Hospital
Outcome results
None listed